Table 2. The results of conventional echocardiographic examination in both protocols (mean ± SD).
| Index | Dehydration protocol | Placebo protocol | ||
|---|---|---|---|---|
| Baseline | After | Baseline | After | |
| IVSd (mm) | 4.12 ± 0.52 | 5.05 ± 0.56* | 3.9 ± 0.74 | 3.5 ± 0.65 |
| LVIDd (mm) | 14.72 ± 1.16 | 12.12 ± 2.26** | 15.73 ± 1.79 | 15.37 ± 2.51 |
| LVFWd (mm) | 4.05 ± 0.79 | 4.52 ± 0.66* | 4.53 ± 1.56 | 3.85 ± 0.67 |
| AoD (mm) | 8.53 ± 0.90 | 8.21 ± 0.65 | 8.42 ± 1.10 | 8.90 ± 0.86 |
| LAD (mm) | 11.72 ± 1.58 | 9.82 ± 0.95* | 10.32 ± 1.04 | 10.57 ± 1.56 |
| HR (bpm) | 186.9 ± 13.9 | 176.6 ± 24.5 | 184.0 ± 20.1 | 182.8 ± 15.2 |
IVSd, interventricular septal thickness at end-diastole; LVIDd, left ventricular internal diameters at end-diastole; LVFWd, left ventricular free wall thickness at end-diastole; AoD, aortic diameter at end-systole; LAD, left atrial diameter at end-systole; HR, heart rate; SD, standard deviation.
*p < 0.05 compared to Placebo protocol; **p < 0.01 compared to Placebo protocol.